This inhibition ability of silibinin was also observed in PD-L1 protein expression in all three NSCLC cells (Figure 5C), indicating the role of PD-L1 in the inhibitory effects of silibinin. The gene discussed is CD274; the disease is non-small cell lung carcinoma.